APGE Stock Price | Apogee Therapeutics, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

Apogee Therapeutics, Inc. Common Stock • APGE

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Apogee Therapeutics, Inc. Common Stock

Ticker

APGE

Trading on

NASDAQ

ISIN

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Michael Thomas Henderson M.D.

Headquarters

221 Crescent Street, Waltham, MA, United States, 02453

Employees

196

Website

apogeetherapeutics.com

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Metrics

BasicAdvanced

Market cap

$2.26B

P/E ratio

EPS

-$3.44

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-217M

Ex dividend date

Price & volume

Market cap

$2.26B

Average daily volume

0.8M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

3.28

Earnings

EPS

-$3.44

EPS estimate (current quarter)

-$1.07

EPS estimate (next quarter)

-$1.10

EBITDA

$-217M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$71.75

52-week Low

$29.10

50-day moving average

$38.15

200-day moving average

$45.79

Short ratio

14.34

Short %

19.48%

Management effectiveness

ROE (TTM)

33.22%

ROA (TTM)

23.46%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

44.6M

Float

39M

Insiders %

11.37%

Institutions %

130.16%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 8 analysts.

Average price target

$93.88

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.64

-$0.61

4.92%

Q1 • 24Beat

-$0.60

-$0.55

9.09%

Q2 • 24Beat

-$0.86

-$0.74

16.22%

Q3 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-49M

∞%

Q3 • 24

$0M

$-67.2M

∞%

Q4 • 24

NaN%

37.13%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$776M

$41.9M

5.40%

Q3 • 24

$754M

$37.2M

4.93%

Q4 • 24

2.88%

11.29%

8.66%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-42.5M

$-146M

$0.4M

$-43.3M

Q3 • 24

$-67.7M

$46.4M

$44.4M

$-67.7M

Q4 • 24

59.24%

131.68%

11,481.20%

56.47%

QoQ growth

QuarterlyAnnual

Sentiment analysis

-1.5

Neutral

+1.5

0.30

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Apogee Therapeutics, Inc. Common Stock share?

Apogee Therapeutics, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does Apogee Therapeutics, Inc. Common Stock have?

Apogee Therapeutics, Inc. Common Stock currently has 44.6M shares.

Does Apogee Therapeutics, Inc. Common Stock pay dividends?

No, Apogee Therapeutics, Inc. Common Stock doesn't pay dividends.

What is Apogee Therapeutics, Inc. Common Stock 52 week high?

Apogee Therapeutics, Inc. Common Stock 52 week high is $71.75.

What is Apogee Therapeutics, Inc. Common Stock 52 week low?

Apogee Therapeutics, Inc. Common Stock 52 week low is $29.10.

What is the 200-day moving average of Apogee Therapeutics, Inc. Common Stock?

Apogee Therapeutics, Inc. Common Stock 200-day moving average is $45.79.

Who is Apogee Therapeutics, Inc. Common Stock CEO?

The CEO of Apogee Therapeutics, Inc. Common Stock is Dr. Michael Thomas Henderson M.D..

How many employees Apogee Therapeutics, Inc. Common Stock has?

Apogee Therapeutics, Inc. Common Stock has 196 employees.

What is the market cap of Apogee Therapeutics, Inc. Common Stock?

The market cap of Apogee Therapeutics, Inc. Common Stock is $2.26B.

What is the P/E of Apogee Therapeutics, Inc. Common Stock?

The current P/E of Apogee Therapeutics, Inc. Common Stock is null.

What is the EPS of Apogee Therapeutics, Inc. Common Stock?

The EPS of Apogee Therapeutics, Inc. Common Stock is -$3.44.

What is the PEG Ratio of Apogee Therapeutics, Inc. Common Stock?

The PEG Ratio of Apogee Therapeutics, Inc. Common Stock is null.

What do analysts say about Apogee Therapeutics, Inc. Common Stock?

According to the analysts Apogee Therapeutics, Inc. Common Stock is considered a buy.